HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohlsson, M. Articles by Tajsharghi, H. Search for Related Content PubMed PubMed Citation Articles by Ohlsson, M. Articles by Tajsharghi, H. Related Collections All Clinical Neurology Muscle disease All Genetics

New morphologic and genetic findings in cap disease associated with β-tropomyosin (TPM2) mutations

From the Departments of Pathology (M.O., A.O., H.T.) and Pediatrics (N.D.), Sahlgrenska University Hospital, Göteborg, Sweden; AP-HP (S.Q.-R., D.A.-S.), Service de Pédiatrie, Hôpital Universitaire Raymond Poincaré, Centre National de Référence des Maladies Neuromusculaires GNMH, Garches, France; and Institut de Myologie (G.B., E.L., M.F.), Groupe Hospitalier Pitie-Salpêtrière, Paris, France.

Address correspondence and reprint requests to Dr. Anders Oldfors, Department of Pathology, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden anders.oldfors{at}gu.se

Objective: Mutations in the β-tropomyosin gene (TPM2) are a rare cause of congenital myopathies with features of nemaline myopathy and cap disease and may also cause distal arthrogryposis syndromes without major muscle pathology. We describe the muscle biopsy findings in three patients with cap disease and novel heterozygous mutations in TPM2.

Methods: Three unrelated patients with congenital myopathy were investigated by muscle biopsy and genetic analysis.

Results: All three patients had early-onset muscle weakness of variable severity and distribution. Muscle biopsy demonstrated in all three patients near uniformity of type 1 fibers and an unusual irregular and coarse-meshed intermyofibrillar network. By electron microscopy, the myofibrils were broad and partly split, and the Z lines appeared jagged. In one of the patients caps structures were identified only by electron microscopy, and in one patient they were identified only in a second biopsy at adulthood. Three novel, de novo, heterozygous mutations in TPM2 were identified: a three–base pair deletion in-frame (p.Lys49del), a three-base pair duplication in-frame (p.Gly52dup), and a missense mutation (p.Asn202Lys).

Conclusions: Mutations in TPM2 seem to be a frequent cause of cap disease. Because cap structures may be sparse, other prominent features, such as a coarse-meshed intermyofibrillar network and jagged Z lines, may be clues to correct diagnosis and also indicate that the pathogenesis involves defective assembly of myofilaments.

GLOSSARY: ATPase = adenosine triphosphatase; CK = creatine kinase; DA = distal arthrogryposis; NADH-TR = nicotinamide adenine dinucleotide–tetrazolium reductase; Tm = tropomyosin.

Supported by grants from the Swedish Research Council (project no. 7122) and Association Française Contre les Myopathies.

Disclosure: The authors report no disclosures.

Received June 10, 2008. Accepted in final form August 29, 2008.

This article has been cited by other articles:

				M. Ohlsson, A. Fidzianska, H. Tajsharghi, and A. Oldfors TPM3 mutation in one of the original cases of cap disease Neurology, June 2, 2009; 72(22): 1961 - 1963. [Full Text] [PDF]